Literature DB >> 11557557

Effects of pituitary adenylate cyclase-activating polypeptide on canine atrial electrophysiology.

M Hirose1, Z Leatmanoratn, K R Laurita, M D Carlson.   

Abstract

We hypothesized that pituitary adenylate cyclase-activating polypeptide (PACAP) activates intracardiac postganglionic parasympathetic nerves and has a different effect than cervical vagal stimulation. We measured effective refractory period (ERP) and conduction velocity at four atrial sites [high right atrium (HRA), low right atrium (LRA), high left atrium (HLA), and low left atrium (LLA)] and minimum atrial fibrillation (AF) cycle length at 12 atrial sites during cervical vagal stimulation and after PACAP in 26 autonomically decentralized, open-chest, anesthetized dogs. PACAP shortened ERP to a similar extent at all four sites (HRA, 58 +/- 2.0 ms; LRA, 60 +/- 6.3 ms; HLA, 68 +/- 11.5 ms; and LLA, 60 +/- 8.3 ms). Low- and high-intensity vagal stimulation shortened ERP at the HRA, but not in the other atrial sites (low-intensity stimulation: HRA, 64 +/- 4.0 ms; LRA, 126 +/- 5.1 ms; HLA, 110 +/- 9.5 ms; and LLA, 102 +/- 11.5 ms; high-intensity stimulation: HRA, 58 +/- 4.2 ms; and HLA, 101 +/- 4.0 ms). Conduction velocity was not altered by any intervention. Minimum AF cycle length after PACAP was similar in both atria but was shorter in the right atrium than in the left atrium during vagal stimulation. After atropine administration, no interventions changed ERP. These results suggest that PACAP shortens atrial refractoriness uniformly in both atria through activation of intrinsic cardiac nerves, not all of which are activated by cervical vagal stimulation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11557557     DOI: 10.1152/ajpheart.2001.281.4.H1667

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  5 in total

1.  PACAP immunoreactivity in human malignant tumor samples and cardiac diseases.

Authors:  Z Szanto; Zs Sarszegi; D Reglodi; J Nemeth; K Szabadfi; P Kiss; A Varga; E Banki; K Csanaky; B Gaszner; O Pinter; Zs Szalai; A Tamas
Journal:  J Mol Neurosci       Date:  2012-05-31       Impact factor: 3.444

2.  Neuronally released vasoactive intestinal polypeptide alters atrial electrophysiological properties and may promote atrial fibrillation.

Authors:  Yutao Xi; Zhi-Yang James Chao; Wen Yan; Shahrzad Abbasi; Xiaomeng Yin; Nilesh Mathuria; Mehul Patel; Christopher Fan; Junping Sun; Geru Wu; Suwei Wang; MacArthur Elayda; Lianjun Gao; Xander H T Wehrens; Shien-Fong Lin; Jie Cheng
Journal:  Heart Rhythm       Date:  2015-03-05       Impact factor: 6.343

3.  PAC₁ receptors mediate positive chronotropic responses to PACAP-27 and VIP in isolated mouse atria.

Authors:  Donald B Hoover; Beatrice M Girard; Jeffrey L Hoover; Rodney L Parsons
Journal:  Eur J Pharmacol       Date:  2013-05-09       Impact factor: 4.432

4.  Atrial Heterogeneity Generates Re-entrant Substrate during Atrial Fibrillation and Anti-arrhythmic Drug Action: Mechanistic Insights from Canine Atrial Models.

Authors:  Marta Varela; Michael A Colman; Jules C Hancox; Oleg V Aslanidi
Journal:  PLoS Comput Biol       Date:  2016-12-16       Impact factor: 4.475

5.  Heterogeneous and anisotropic integrative model of pulmonary veins: computational study of arrhythmogenic substrate for atrial fibrillation.

Authors:  Oleg V Aslanidi; Michael A Colman; Marta Varela; Jichao Zhao; Bruce H Smaill; Jules C Hancox; Mark R Boyett; Henggui Zhang
Journal:  Interface Focus       Date:  2013-04-06       Impact factor: 3.906

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.